Walldorf, Germany

Thomas Brefort

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.9

ph-index = 1


Location History:

  • Ebersberg, DE (2020)
  • Walldorf, DE (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Thomas Brefort: Advancements in Diagnostic Methods

Introduction

Thomas Brefort is a distinguished inventor based in Walldorf, Germany, recognized for his significant contributions to the field of medical diagnostics. With two patents to his name, he focuses on the development of innovative methods that utilize microRNA (miRNA) as biomarkers to improve patient diagnosis for various health conditions.

Latest Patents

Thomas Brefort's latest patents highlight his dedication to advancing medical technology. His first patent, titled "Determination of miR-423-5p in heart failure," introduces methods, kits, and applications for diagnosing heart failure through a specific miRNA biomarker found in blood samples. This innovative approach opens up new avenues for non-invasive heart failure diagnostics.

His second patent, "MiRNAs as non-invasive biomarkers for inflammatory bowel disease," provides a method for diagnosing Inflammatory Bowel Disease (IBD) by determining expression profiles of specific miRNAs compared to a reference. Furthermore, it includes a kit designed to facilitate the diagnosis of IBD, showcasing his commitment to enhancing health diagnostics.

Career Highlights

Thomas Brefort is currently affiliated with Hummingbird Diagnostics GmbH, where his pioneering research continues to shape the future of diagnostic tools in the medical field. His focus on miRNAs demonstrates his innovative approach and commitment to leveraging technology for better health outcomes.

Collaborations

Throughout his career, Thomas has collaborated with notable peers, including Markus Beier and Andre Franke. These collaborations have helped bolster his research efforts, bringing together diverse expertise to enhance the development of diagnostic innovations.

Conclusion

In conclusion, Thomas Brefort exemplifies the spirit of innovation in the realm of medical diagnostics. His inventions not only contribute to advancements in detecting heart failure and inflammatory bowel disease but also reflect the potential of utilizing miRNA as critical biomarkers in healthcare. As he continues his work at Hummingbird Diagnostics GmbH, the impact of his contributions is likely to resonate throughout the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…